NASDAQ:HPTX »

Company News » Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hyperion Therapeutics, Inc. Stockholders
Business Wire - September 10, 2014, 22:57 GMT

Kirby McInerney LLP is investigating potential claims against the Board of Directors of Hyperion Therapeutics, Inc. (“Hyperion” or the “Company”) (NASDAQ:HPTX) concerning the termination of the development of its Type 1 diabetes drug due to the manipulation of trial data. On September 8, 2014, the Company announced that it is terminating development of DiaPep277 for

Read full story »
Company News » EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Hyperion Therapeutics, Inc. — HPTX
Business Wire - September 8, 2014, 17:39 GMT

The Rosen Law Firm, P.A. announces that it is investigating potential securities claims against Hyperion Therapeutics, Inc. (NASDAQ:HPTX) resulting from allegations that the Company may have issued materially false statements to investors. On September 8, 2014, Hyperion Therapeutics shocked the market when it announced that it would terminate the development of its diabetes drug, DiaPep277,

Read full story »

Forex Broker Spreads »

Iron FX	1.11156/1.11128	2.8
XM Markets	1.09948/1.09928	2
FxPro	1.10184/1.10171	1.3
FXCM	1.13943/1.13912	3.1

Most Popular Articles »

© 2014 Finances International Ltd. All Rights Reserved

Risk Disclosure: Finances.com will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Currency trading on margin involves high risk, and is not suitable for all investors. Before deciding to trade foreign exchange or any other financial instrument you should carefully consider your investment objectives, level of experience, and risk appetite.